OR WAIT null SECS
April 22, 2022
LC–UV assay and organic impurities for paliperidone drug substance based on USP monograph where a L1 (C18) column with 100 x 4.6 mm, 3 µm dimensions was used
LC–MS/MS method to separate furosemide and its metabolite using three different columns: Kinetex 2.6 µm Biphenyl, Luna Omega 1.6 µm C18, and Luna Omega 1.6 µm Polar C18
Luna Omega 1.6µm, 3µm, and 5µm HPLC/UHPLC columns culminate 20 years of technological prowess, advancements, and innovation.
Easily determine the allowable adjustments that can be made to European Pharmacopoeia (EP) methods and find the right column for your method.
Quickly view allowable adjustments outlined by the United States Pharmacopeia (USP) and select the proper Phenomenex column for your monograph using this simple guide.
Analysis of ABN7 test mix used to assess scalability for Luna Omega C18 columns across a range of particle sizes (1.6 µm, 3 µm, and 5 µm) in three different dimensions.
Improve United States Pharmacopeia (USP) method performance with allowable adjustments
April 21, 2022
In this application note we demonstrate the excellent performance of Sapiens-624MS columns for the analysis of e-liquids based on ISO 20714.
April 18, 2022
The fight against cancer employs many tools. Paclitaxel, a compound found in the bark of the Pacific yew tree, is one that that has been found to make a big difference.
March 24, 2022
The pharma industry is embracing the challenge of sustainability by using greener solvents. A GC–MS method for analyzing 32 green solvents is presented.